Park-Ohio Holdings Corp
PKOH
47.55
-0.73
-1.51%
Park-Ohio Holdings Corp
US · PKOH
#3511 by market cap
47.55
-0.73
-1.51%
Live - 5344 symbols - heartbeat 446s ago
· 2026-10-08 09:48
After-hours
48.28
0.00%
- Market cap
- 689.00M
- P/E (TTM)i
- 25.43
- P/Bi
- 1.76
- EPSi
- 1.70
- Div yieldi
- 1.05%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on PKOH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.40, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.45% YoY
Margins
- Gross margin
- 16.96%
- Operating margin
- 5.10%
- Net margin
- 1.49%
Key ratios & quality
- Enterprise valuei
- 1.28B
- Altman Z-Scorei
- 2.40
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.66B | 1.62B | 1.15B | 1.28B | 1.49B | 1.66B | 1.66B | 1.60B |
| Gross profit | 271.50M | 260.30M | 165.30M | 177.90M | 210.50M | 271.40M | 281.40M | 271.20M |
| Selling & admin expenses | 176.10M | 177.20M | 140.20M | 155.90M | 162.20M | 181.50M | 187.40M | 189.60M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 95.40M | 83.10M | 25.10M | 22.00M | 48.30M | 89.90M | 89.00M | 81.60M |
| Pretax profit | 71.80M | 54.90M | -1.80M | -1.10M | 10.70M | 41.50M | 44.40M | 23.80M |
| Tax | 16.60M | 15.20M | -1.30M | -1.00M | -700.00K | 8.50M | 4.90M | 2.80M |
| Net profit | 55.20M | 39.70M | -4.80M | -26.00M | -12.90M | 6.80M | 29.10M | 20.00M |
| Basic EPS | 4 | 3 | 0 | -2 | -1 | 1 | 2 | 2 |
| Diluted EPS | 4.28 | 3.12 | -0.37 | -2.07 | -1.17 | 0.62 | 2.40 | 1.70 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 405.40M | 400.10M | 398.60M | 395.00M | 421.00M | 440.10M |
| Gross profit | 68.10M | 68.20M | 66.60M | 68.30M | 72.70M | 78.90M |
| Selling & admin expenses | 48.20M | 46.80M | 46.50M | 48.10M | 51.70M | 53.10M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 19.90M | 21.40M | 20.10M | 20.20M | 21.00M | 25.80M |
| Pretax profit | 9.70M | 10.70M | 4.50M | -1.10M | 9.50M | 14.40M |
| Tax | 1.90M | 1.80M | -400.00K | -500.00K | 1.60M | 2.40M |
| Net profit | 7.80M | 8.90M | 4.70M | -1.10M | 7.90M | 12.00M |
| Basic EPS | 1 | 1 | 0 | 0 | 1 | 1 |
| Diluted EPS | 0.60 | 0.66 | 0.38 | 0.07 | 0.57 | 0.86 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 720.60M | 725.70M | 706.40M | 775.50M | 932.40M | 824.40M | 836.00M | 852.50M |
| Cash & ST investments | 55.70M | 56.00M | 55.00M | 54.10M | 58.20M | 54.80M | 53.10M | 44.80M |
| Inventory | 317.80M | 327.20M | 310.90M | 352.40M | 406.50M | 411.10M | 422.90M | 420.90M |
| Total assets | 1.21B | 1.31B | 1.30B | 1.36B | 1.44B | 1.34B | 1.37B | 1.42B |
| Total current liabilities | 298.90M | 305.00M | 307.10M | 349.00M | 448.60M | 363.60M | 361.10M | 366.60M |
| Short-term debt | 17.90M | 28.70M | 24.50M | 16.90M | 22.10M | 20.00M | 19.10M | 19.20M |
| Long-term debt | 547.50M | 535.00M | 506.20M | 586.90M | 655.10M | 633.40M | 618.30M | 620.70M |
| Total liabilities | 895,900,000.00 | 960,800,000.00 | 942,600,000.00 | 1,035,200,000.00 | 1,168,700,000.00 | 1,050,800,000.00 | 1,028,000,000.00 | 1,036,800,000.00 |
| Total equity | 312.60M | 349.60M | 357.90M | 324.80M | 267.90M | 289.90M | 337.10M | 382.80M |
| Retained earnings | 265.90M | 298.20M | 290.50M | 259.40M | 238.80M | 240.10M | 265.20M | 281.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 870.00M | 873.80M | 887.00M | 852.50M | 871.80M | 897.90M |
| Cash & ST investments | 54.50M | 45.60M | 50.80M | 44.80M | 46.70M | 48.30M |
| Inventory | 419.80M | 425.90M | 428.40M | 420.90M | 426.60M | 427.60M |
| Total assets | 1.41B | 1.42B | 1.44B | 1.42B | 1.44B | 1.47B |
| Total current liabilities | 360.80M | 336.20M | 346.80M | 366.60M | 362.60M | 374.50M |
| Short-term debt | 19.00M | 19.80M | 19.20M | 19.20M | 16.90M | 18.80M |
| Long-term debt | 642.10M | 656.70M | 659.10M | 620.70M | 646.20M | 652.60M |
| Total liabilities | 1,057,000,000.00 | 1,045,400,000.00 | 1,057,800,000.00 | 1,036,800,000.00 | 1,055,500,000.00 | 1,078,200,000.00 |
| Total equity | 354.80M | 376.30M | 378.80M | 382.80M | 381.00M | 392.50M |
| Retained earnings | 271.70M | -- | 282.60M | 281.80M | 288.10M | 298.40M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 54.80M | 63.70M | 58.60M | -12.20M | -26.60M | 53.40M | 35.00M | 42.30M |
| Depreciation & amortization | 36.30M | 34.20M | 28.20M | 30.80M | 30.20M | 31.70M | 33.60M | 33.00M |
| Free cash flow | 9.70M | 23.60M | 38.30M | -34.50M | -53.50M | 25.20M | 3.60M | 2.00M |
| Dividends paid | -6.40M | -7.00M | -3.20M | -7.00M | -7.00M | -7.40M | -7.20M | -7.80M |
| Stock buybacks / issuance | -9.00M | -900.00K | -7.50M | -2.50M | 0 | 0 | 30.40M | 0 |
| Ending cash balance | 55.70M | 56.00M | 55.00M | 54.10M | 58.20M | 54.80M | 53.10M | 44.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -10.00M | -13.70M | 17.30M | 48.70M | -7.80M | 9.20M |
| Depreciation & amortization | 8.30M | 8.20M | 8.30M | 8.20M | 8.30M | 8.40M |
| Free cash flow | -19.50M | -21.10M | 6.60M | 36.00M | -20.30M | -1.80M |
| Dividends paid | -1.80M | -1.80M | -2.40M | -1.80M | -1.80M | -1.80M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 54.50M | 45.60M | 50.80M | 44.80M | 46.70M | 48.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.64 | 12.17 | -1.32 | -7.53 | -4.98 | 2.91 | 10.41 | 6.69 |
| ROA %i | 4.58 | 3.06 | -0.34 | -1.86 | -1.02 | 0.56 | 2.35 | 1.71 |
| ROIC %i | 9.56 | 6.90 | 1.62 | -0.07 | 1.28 | 4.49 | 7.53 | 6.41 |
| 5-year avg ROE %i | 19.16 | 16.30 | 11.12 | 6.67 | 3.39 | 0.25 | -0.10 | 1.50 |
| EBIT margin %i | 6.40 | 5.48 | 1.78 | -0.17 | 2.98 | 5.22 | 5.54 | 4.46 |
| FCF / sales %i | 0.59 | 1.46 | 3.32 | -- | -- | 1.52 | 0.22 | 0.13 |
| Current ratioi | 2.41 | 2.38 | 2.30 | 2.22 | 2.08 | 2.27 | 2.32 | 2.33 |
| Quick ratioi | 1.29 | 1.24 | 1.17 | 0.95 | 0.73 | 0.87 | 0.84 | 0.85 |
| Debt / assetsi | 46.79 | 47.89 | 46.06 | 47.77 | 50.18 | 51.30 | 48.88 | 47.22 |
| LT debt / equityi | 183.11 | 178.43 | 166.91 | 201.46 | 272.44 | 238.16 | 195.92 | 170.94 |
| Interest coveragei | 3.09 | 2.62 | 0.76 | -0.08 | 1.32 | 1.92 | 1.94 | 1.50 |
| Revenue CAGR (3Y) %i | 4.24 | 8.22 | -6.58 | -8.34 | -2.65 | 12.94 | 9.05 | 2.32 |
| Net income CAGR (3Y) %i | 3.67 | 6.78 | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 5.76 | -19.00 | 26.77 | -- | -- | -13.02 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.57 | 8.36 | 6.56 | 6.69 | 6.48 | 6.95 |
| ROA %i | 2.17 | 1.98 | 1.64 | 1.71 | 1.66 | 1.83 |
| ROIC %i | 7.13 | 6.68 | 6.10 | 6.41 | 6.36 | 6.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.30 | 5.16 | 4.73 | 4.46 | 4.48 | 4.67 |
| FCF / sales %i | -- | -- | -- | 0.13 | 0.07 | 1.24 |
| Current ratioi | 2.41 | 2.60 | 2.56 | 2.33 | 2.40 | 2.40 |
| Quick ratioi | 0.92 | 0.98 | 0.94 | 0.85 | 0.90 | 0.90 |
| Debt / assetsi | 49.28 | 49.89 | 49.42 | 47.22 | 48.12 | 47.87 |
| LT debt / equityi | 193.79 | 185.80 | 184.29 | 170.94 | 177.75 | 175.20 |
| Interest coveragei | 1.88 | 1.82 | 1.64 | 1.50 | 1.48 | 1.55 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Supply Technologies is the largest reported line at 47.56% of revenue, across 3 reported segments.
- Engineered Products follows at 29.40%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Supply Technologies47.56%
Engineered Products29.40%
Assembly Components23.04%
Quote time 2026-10-08 09:48:11 · For reference only, not investment advice and not tailored to your situation.